Scientific Program
Monday 5 September 2022
- 1 pm – 4.50 pm: Young scientists
Tuesday 6 September 2022
- 8.15 am – 9.15 am: Performance-enhancing drugs and behaviour alteration (M Huestis & A Salomone)
- 9.15 am – 10.15 am: New analytical approaches – 1 (M Concheiro & F Saint-Marcoux)
- 10.45 am – 12.45 pm: Recreational drugs and behaviour alteration (S Pichini & A Verstraete)
- 2 pm – 4 pm: Alternative specimens (C Jurado & P Kintz)
- 4.30 pm – 6.30 pm: Clinical forensic toxicology (S Wille & H Maurer)
- 6.30 pm – 6.50 pm : NPS open meeting (NPS committee)
- 8.15 am – 6 pm: Posters
Wednesday 7 September 2022
- 8.15 am – 10.15 am: Postmortem toxicology 1 (H Chung & D Gerostamoulos)
- 8.15 am – 10.15 am: session 1 DPC SFTA in French (parallel session) (V Dumestre-Toulet & JP Goullé)
- 10.45 am – 12.45 pm: Recent trends in screening procedures (D Favretto & I Ojanpera)
- 10.45 am – 12.30 pm: session 2 DPC SFTA in French (parallel session) (AS Lemaire-Hurtel & JM Gaulier)
- 2 pm – 4 pm: Metabolism and metabolomics (B Desharnais & M Augsburger)
- 2 pm – 5.30 pm: Free topics SFTA in French (parallel session) (AL Pélissier & A Larabi)
- 4.30 pm – 5.30 pm: Plants intoxications (M Martinez & N Lemos)
- 8.15 am – 5 pm: Posters
Thursday 8 September 2022
- 8.15 am – 10.15 am: Postmortem toxicology 2 (A Evans & D Isenschmid)
- 10.15 am – 12.45 pm: New analytical approaches – 2 (M Swortwood & R Kronstrand)
- 2 pm – 3 pm: Free topics (H Teixeira & J Beyer)
- 8.15 am – 3.30 pm: Posters
Oral presentations
Tuesday 6 September 2022 morning
Performance-enhancing drugs and behaviour alteration (M Huestis & A Salomone)
- O1. Akgür SA. Cut-off dilemma: differences from the forensic and clinic perspective
- O2. Sempio C. Acute effects of Cannabinoid Consumption on Endocannabinoid Levels
- O3. Shimko KM. Prevalence and emergence of steroidal and non-steroidal anabolic agents in the Australian community measured through wastewater analysis
- O4. Thiebot P. Corticoids identification in a lipolytic product promoted by two influencers
- O5. Tou K. Complementary biomarker detection for bisphosphonate use in race horses
New analytical approaches – 1 (M Concheiro & F Saint-Marcoux)
- O6. Birk L. Expanding the use of cork as biosorbent through the determination of new psychoactive substances in postmortem blood samples
- O7. Desharnais B. Case studies in automation of forensic toxicology practices with R
- O8. Gampfer T. A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay – Exemplified for nine compounds
- O9. Gottardo R. Intentional and unintentional nitrite intoxications: a novel diagnostic strategy based on the direct ion determination by capillary electrophoresis
- O10. Gunnar T. Wastewater-based epidemiology combined with forensic toxicological information: trends in drug use and impact of law enforcement activities
Recreational drugs and behaviour alteration (S Pichini & A Verstraete)
- O11. Deventer MH. New generic ban evading synthetic cannabinoids shaking up the market?
- O12. Grafinger KE. Investigation of the μ and κ-opioid receptor activation by eight new synthetic opioids using the [35S]-GTPγS assay: U-47700, isopropyl U 47700, U-49900, U-47931E, N-methyl U-47931E, U-51754, U-48520 and U-48800
- O13. Di Rago M. Toxicity of heroin laced with synthetic opioid β-U10 and etizolam
- O14. Lee D. Would CNS depressants cause paradoxical aggressive driving behaviors?
- O15. Morais J. New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System
- O16. Persson M. Characterisation of the monoamine transport inhibition of 28 new psychoactive stimulants
- O17. Lo Faro AF. Human methylone, MDMA and metabolites’ plasma concentrations by a new LC-MS/MS method after controlled administration of methylone and MDMA
- O18. Fabresse N. Serotonin syndrome onset following 25H-NBOH and MDPHP consumption: a case report
- O19. Pulver B. Review of five years of comprehensive NPS analytics and insights into the substance identification workflow of the ADEBAR project
- O20. Augsburger M. Interest of drug checking supply: results of 3 years of activity in Geneva
Tuesday 6 September 2022 afternoon
Alternative specimen (C Jurado & P Kintz)
- O21. Adamowicz P. Can scene bloodstains be used to quantify drug concentration at the moment of injury?
- O22. Busardò FP. Assessment of prenatal exposure to alcohol and gestational consumption by EtG testing in neonatal meconium and maternal hair and neonatal: first Italian national survey
- O23. Cobo-Golpe M. Detection of hair metabolome changes in cocaine users using untargeted metabolomics
- O24. Concheiro M. Fast and sensitive method for the determination of 17 designer benzodiazepines in hair by Liquid Chromatography Tandem Mass Spectrometry
- O25. Dumitrascu C. Phosphatidylethanol in whole blood: a complementary biomarker to ethyl glucuronide in hair
- O26. Hakim F. Added value evidence of a simultaneous determination of two phosphatidylethanol isoforms and ethylglucuronide in dried blood spots in forensic contexts
- O27. Oliverio S. Impact of hemp-based cosmetic products on cannabis testing in hair
- O28. Paniagua-González L. Driving Under the Influence of Drugs (DUID) profiling in Spain: data from oral fluid results between 2016 and 2022, including the effect of COVID-19 lockdown
- O29. Ramirez Fernandez M. Passive exposure to cocaine on a professional level: importance of considering relevant interpretation parameters
- O30. Rodda LN. Bladder wash as an alternative urine specimen for postmortem toxicology
Clinical & forensic toxicology (S Wille & H Maurer)
- O31. Bellouard M. Extrapyramidal syndrome in a breastfed child, relevance of toxicological analysis
- O32. Ferrari L. Massive intoxication due to cocaine adulterated with carfentanil
- O33. Gesseck A. The analysis of drugs in neonates using an ad hoc oral fluid collection device to develop a prediction model for neonatal abstinence syndrome and provide maternal support
- O34. Høiseth G. Possibility of falsely low levels of the alcohol marker phosphatidylethanol in patients with high alcohol consumption and hemolytic conditions
- O35. Jacobs C. Adherence monitoring of antihypertensive drugs in finger prick blood microsamples – Development and validation of an analytical procedure
- O36. Kuchar M. Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine (DCK) in Wistar rats
- O37. Lamoriniere M. Coconut crab intoxication in New Caledonia from January 2016 to April 2022
- O38. Morini L. Ethyl glucuronide in hair: a 5-years retrospective cohort study among drivers under the influence of psychoactive substances and alcohol
- O39. Schumann J. An illicit drug early warning system in Victoria, Australia: the role of forensic toxicology in clinical casework
- O40. Wartmann Y. Finding CYP2D6 activity biomarkers by correlating MDMA pharmacokinetic parameters to untargeted metabolomics data
Wednesday 7 September 2022 morning
Postmortem toxicology – 1 (H Chung & D Gerostamoulos)
- O41. Ameline A. Fate of fentanyl after formalin-fixed tissues: about an authentic case and a stability study
- O42. Bottinelli C. Analysis of human insulin and its therapeutic analogs by LC-HRMS: 4 years feedback and perspectives
- O43. Bosman I. A case series of suicides by sodium azide ingestion
- O44. Di Fazio V. Poisoning with atropine-based eye drops: an almost perfect murder?
- O45. Doerr AA. Deadly monointoxication after ingestion of 4F-MDMB-BICA
- O46. Elmsjö A. Postmortem metabolic fingerprinting in death investigations
- O47. Favretto F. Chlopyrifos fatal intoxication: homicide or suicide?
- O48. Gagen S. The significance in detecting and determining out-of-scope findings for volatile organic compounds in forensic casework
- O49. Hikin L. Sodium nitrite poisoning; a case series of 15 fatalities
- O50. Logan B. Increasing incidence of xylazine as a toxic adulterating substance in postmortem forensic toxicology casework
Recent trends in screening procedures (D Favretto & I Ojanpera)
- O51. Griffeuille P. Ultrafast measurement of drugs using Probe Electrospray Ionization Mass Spectrometry (PESI-MS) and isotope dilution: an example with metformin
- O52. Houzé P. Micro sampling, a new trend in toxicological screening?
- O53. Janssens LK. Large-scale activity-based SCRA screening on patient serum samples: CB1 bioassay supported by machine learning
- O54. Kebbabi C. What is the added value of liquid chromatography-tandem mass spectrometry for routine urine drug screening in clinical situations?
- O55. Magny R. Synthetic cannabinoids identification in e-liquid and biological samples through molecular network approach
- O56. Pichini S. The role of analytical pharmacotoxicology in adressing the main functions of the National Early Warning System on NPS
- O57. Trobbiani S. A method for the sensitive targeted screening of synthetic cannabinoids and opioids in whole blood by LC-QTOF with simultaneous suspect screening using HighResNPS.com
- O58. Ververi C. Phosphatidylethanol (Peth) in Dried Blood Spots: development, validation and comparison between LC-MS/MS and QTOF methods
- O59. Wille S. Practical High Resolution Mass Spectrometry screening approach and propositions for adequate identification criteria as well as quality assurance and validation specifics
- O60. Zarrouk E. Quantitative screening of pesticides and their metabolites in human matrices: are we ready to switch to high resolution mass spectrometry?
Wednesday 7 September 2022 afternoon
Metabolomic and metabolism (B Desharnais & M Augsburger)
- O61. Elbourne M. Metabolomic analysis of equine urine to determine route of altrenogest administration
- O62. Gerace E. Metabolic study of methoxpropamine (MXPr) in rats and determination of its metabolites in biological samples by UHPLC-QTOF-HRMS
- O63. Giorgetti A. Synthetic cannabinoids carrying an ethyl ester moiety: human phase I metabolism and prevalence of 5F-EDMB-PICA and EDMB-PINACA
- O64. Jinni Y. Investigation of metabolic biomarkers: a metabolomics approach
- O65. Keen B. A statistical focus on doping using a metabolomics approach
- O66. Kemenes K. Metabolism of the synthetic cathinone alpha-pyrrolidinoisohexanophenone in humans using UHPLC-MS-QToF
- O67. Pelletier R. 4-Chloro-Pyrrovalerone in silico, in vitro, in vivo metabolism studies using molecular networking
- O68. Scholz M. Metabolomics for determination of non-substance related sleepiness
- O69. Verougstraete N. Identification of etazene metabolites in human urine by LC-HRMS
- O70. Schwelm HM. 3-Methyl-PCP – in vitro and in vivo metabolism in humans and post-mortem investigation of a fatal intoxication
Plants intoxications (M Martinez & N Lemos)
- O71. Gaillard Y. The crime was so perfect! So, why not another time?
- O72. Gish A. Analytical strategy to document horse fatalities related to Oenanthe crocata poisoning
- O73. Flament E. Determination of orellanine and muscarine in biological fluids in suspected or proven poisoning cases: about several cases
- O74. Petzel-Witt S. A case of attempted murder using blue monkshood due to unfulfilled desires
- O75. Vevelstad M. Plant toxin poisoning – a disguised diagnosis?
Thursday 8 September 2022 morning
Postmortem toxicology – 2 (A Evans & D Isenschmid)
- O76. Kacinko S. Tetrahydrozoline: death by eyedrops
- O77. Morley S. Is carbon monoxide testing required on all deaths in the elderly?
- O78. Ojanperä I. Fatal concentrations of antidepressants and antipsychotics in post-mortem blood
- O79. Orfanidis A. Analysis, stability and distribution of pharmaceuticals and drugs of abuse over a period of one year in formalin-fixed liver and formalin solutions
- O80. Rock KL. Detection of novel benzodiazepines in post-mortem cases
- O81. Rygaard K. Citalopram and escitalopram in hair segments from deceased individuals with mental illnesses
- O82. Schwelm HM. 5-Methylmethiopropamine (5-MMPA, mephedrene) – human metabolism and post-mortem investigation of a fatal intoxication
- O83. Söderberg C. Postmortem reference concentrations of elements in blood and urine
- O84. Walton S. N,N-Dimethylpentylone – An emerging NPS stimulant of concern in the United States
- O85. Ward LJ. Can postmortem metabolomics be used as a tool in the identification of deaths attributed to hypoglycaemia
New analytical approaches – 2 (M Swortwood & R Kronstrand)
- O86. Jurasek B. The versatility of the XRPD for the drug detection
- O87. Luginbühl M. Addressing new possibilities and new challenges: automated nondestructive hematocrit normalization for Dried Blood Spots
- O88. Mardal M. A new strategy for efficient retrospective data analyses for Designer Benzodiazepines in large LC-HRMS datasets
- O89. Massano M. Wastewater surveillance for different classes of pharmaceutical drugs: focus on psychotropic drugs and their metabolites
- O90. Moosmann B. A novel receptor binding-based assay to screen for opiates and (synthetic) opioids in human urine samples
- O91. Müller A. Formation of ethyl glucuronide by beta-Glucuronidase
- O92. Quireyns M. Temporal monitoring of pharmaceutical consumption using a wastewater-based epidemiologic approach
- O93. Romolo FS. Nuclear techniques in forensic toxicology
- O94. Schneider TD. Uncovering urine adulteration attempts in forensic toxicology: a LC-MS based proteomics approach
- O95. Weinmann W. Optimization of DBS-self sampling for PEth in a drinking experiment with standard DBS cards and with a new design of volumetric DBS card
Thursday 8 September 2022 afternoon
Free topics (H Teixeira & J Beyer)
- O96. Knapp-Gisclon A. Analysis of an ampoule found on a WW2 German soldier: poison or medicine?
- O97. Green H. CB1 activity of three classes of synthetic cannabinoids and their metabolites – The tail needs to know what the head is doing
- O98. Holt A. Impact of vaping ethanol on the Roadside Field Sobriety Test in a clinical setting
- 099. Willeman T. New insights into buprenorphine and methadone related fatalities at therapeutic concentration: 11-year results from french national DRAMES Study
- O100. Marillier M. Poisoning at the court of the Sun King, the Affair of the Poisons
Société Française de Toxicologie Analytique
Mercredi 7 septembre 2022
Cannabidiol : mise à jour des connaissances
(réglementaires, cliniques et analytiques) dans un contexte d’actualité
8h15 – 8h45 : Accueil. L’émargement des participants est obligatoire.
8h45 -10h15: SFTA – DPC– Session 1 (V Dumestre-Toulet & JP Goullé)
Approfondissement des connaissances
- Pr Jean-Pierre Goullé. Règlementation
- Pr Céline Verstuyft. Aspects pharmacologiques
- Dr Bertrand Brunet. Aspects analytiques
- Pr Nadine Attal. Expérimentation de Cannabis Thérapeutique
10h15-10h45 : Pause-café
10h45 -12h30: SFTA – DPC– Session 2 (AS Lemaire-Hurtel & JM Gaulier)
Approfondissement des connaissances (Suite)
- Dr Juliana Tournebize Cigarette électronique
- Dr Laurie Gheddar Sport et dopage
Table Ronde: Aspects pratiques Illustrations des problématiques par des mises en situation proposées par les orateurs (présentation de cas et/ou Frequently Asked Questions,) et des réponses à y apporter.
Echanges avec les participants
12h30 : Clôture session DPC
SFTA Session Thèmes libres (AL Pélissier & A Larabi)
- O101. Aknouche F. Administration de 5-APB dans une discothèque en Nouvelle-Calédonie : description de deux cas
- O102. André C. Myocardial infarction and cannabis consumption: two years of data collection in CHU Amiens-Picardie
- O103. Arbouche N. Difficulties in interpreting a therapeutic blood concentration of insulin lispro in postmortem blood: a case report
- O104. Becam J. Cocaine pediatric poisoning: a case series
- O105. Blanchot A. Bariatric surgery and changes in metformin distribution: about a fatal case
- O106. Dugues P. Targeted and untargeted screening of new psychoactive substances (NPS) and classical drugs of abuse in Paris using hair testing: A 10-years study (2012-2021)
- O107. Grenier C. 2-MeOPP positive hair result in case of urapidil treatment
- O108. Feisthauer E. Very bad deep… When the scuba tank smells like smoke
- O109. Lelong J. When a toast becomes fatal, the story of two children and sodium fluoroacetate
- O110. Monteil-Ganière C. LC-HRMS toxicological screening and biological sample preparation: evaluation of extraction by turbulent flow chromatography and protein precipitation procedures
- O111. Salle S. Interest of nails analysis to investigate synthetic cannabinoid exposure? a case report
- O112. Zebbiche Y. Identification des sources d’exposition au plomb : intérêt de l’analyse isotopique par ICP-MS
Poster Presentations
| Posters can be displayed beginning Monday, September 5th at 12:00 p.m. (room Le Nôtre) and continuing throughout the meeting dates . To facilitate installation, the poster number will be displayed on the dedicated panel. Authors must pick up their posters after the coffee break on Thursday, September 8th, at 3.30 p.m. | |
| P1 | Čabala R. Are the results of immunochemical screening of urine for synthetic cannabinoids affected by other common drugs? – Pilot statistical study on samples from detention prisons |
| P2 | Abdennour S. Cannabis poisoning in infants: a case report |
| P3 | Abdennour S. Development and validation of UPLC-UV-DAD method for the determination of oleandrin in Nerium oleander dried leaves collected in Eastern Algeria |
| P4 | Abdennour S. Pharmacokinetics of oleandrin after administration of a Nerium oleander extract in mice |
| P5 | Abdennour S. Validation of a colorimetric method for measuring urinary thiocyanates applicable to cyanide poisoning |
| P6 | Abdullah A. Phytochemical effects of genistein and daidzein on sex hormones and corticosterone in female adult rats exposed to Chlorpyrifos |
| P7 | Abid AI. Liver as an alternative specimen for carbon monoxide detection when blood is unavailable |
| P8 | Aboutara N. One large beer, please! Synthesis of phosphatidylethanol 16:0/18:1 and 16:0/18:2 after consumption of low amounts of alcohol |
| P9 | Akgür SA. Caution in workplace drug testing: controlled drugs |
| P10 | Akgür SA. Methyl alcohol intoxication and concomitant psychoactive substances in forensic cases |
| P11 | Alzeer S. Determination of caffeine and paraxanthine concentrations in urine samples of male clients in three Syrian gymnasiums |
| P12 | Andresen Bergström M. Drug analysis of residues from used syringes collected at a syringe exchange programme in Gothenburg, Sweden |
| P13 | Andresen-Streichert H. Ketamine in DUID cases in the greater Cologne area. A case series |
| P14 | Arezki Boukerma K. Fatal cocaine poisoning in a body stuffer |
| P15 | Arezki Y. Application of the Evidence MultiSTAT benchtop analyser to the fast (under 30 minutes), simultaneous, semi-quantitative determination of 29 drugs of abuse from one urine sample |
| P16 | Arnault A. Dramatical outcome following the consumption of a joint containing the synthetic cannabinoid MDMB-4en-PINACA: a case report |
| P17 | Avci Akca A. Analysis of drug-impregnated paper from English prisons between 2018 And 2020 |
| P18 | Baik H. The method of detection ADB-BUTINACA in urine and application in forensic cases |
| P19 | Bambagiotti G. Effects of subtoxic 3-methylmethcathinone concentrations on neuronal cell electrical properties |
| P20 | Barguil Y. Hair cannabinoids for distinguishing acute psychosis from chronic psychosis in cannabis users with brief psychotic disorder |
| P21 | Berardinelli D. 4-Hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) in vitro human metabolism |
| P22 | Boumba V. Quantification of brorphine in saliva using Fabric Phase Sorptive Extraction (FPSE) and tandem LC-MS/MS |
| P23 | Brown-Baxter N. Validation of Gas-Chromatography Mass-Spectrometry (GC-MS) qualitative method for detection of paraquat by sodium borohydride-platinum chloride chemical reduction |
| P24 | Brunetti P. Human metabolism of AP-238. A novel synthetic opioid spreading in the shadow of “fentalogues” |
| P25 | Burgueño MJ. Did they really drink alcohol? Key role of ethyl glucuronide and ethyl sulfate in blood and vitreous humour in the interpretation of postmortem alcohol findings |
| P26 | Byrska B. Chemical composition of Ayahuasca seized in Poland |
| P27 | Castro MJ. Metronidazole: the new cocaine adulterant in Uruguay? |
| P28 | Cattell C. Automating DUID methods using robotics for Rapid High Throughput sample preparation – Analysis of Delta-9-Tetrahydrocannabinol and its major metabolite Delta-9-Tetrahydrocannabinol acid in whole blood |
| P29 | Chang HT. Identification of urinary biomarkers of synthetic cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID and BZO-CHMOXIZID from authentic urine samples in singapore |
| P30 | Chebli A. Literature review on pregabalin and the risk of addiction |
| P31 | Chèze M. Drug-facilitated crimes: do not forget to test for GHB in hair! |
| P32 | Cihlarova P. The UHPLC-MS/MS determination of ostarine in food supplements for athletes |
| P33 | Coopman V. High-resolution quadrupole time-of-flight mass spectrometry, a powerfull technique to include in analytical scheme for the identification of drugs and chemicals in seizures: a case study |
| P34 | Copeland C. China versus the world: impact of international drug policy on post-mortem stimulant detections in England, Wales and Northern Ireland |
| P35 | Coquerel A. Post-mortem delay and stress / hypoxia markers in the sudden infant death syndrome (SIDS) |
| P36 | Crump K. The emerging trend of suicide using nitrite/nitrate in Victoria, Australia |
| P37 | Czarny J. Comparison of screening with the use of Biochip Array Technology to the direct analysis of 521 psychoactive compounds and their residues with the use of LC-MS/MS method – does it mean the end of an era for immunochemical research? |
| P38 | Daglioglu N. The systematic investigation of the role of adulterants into the postmortem redistribution of heroin |
| P39 | Dalsgaard PW. Multi-library synchronization for suspect screening using LC-HRMS: the importance of InChIkeys |
| P40 | Déglon J. Quantification of phosphatidylethanol combining dried blood spots sampling with Orbitrap-based LC-HRMS platform: method validation and proficiency testing |
| P41 | Deventer MH. Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor |
| P42 | Di Rago M. Rapid semi-automated simplified liquid extraction (SLE) and data processing for 43 drugs of abuse in oral fluid |
| P43 | Djamaa S. Intoxication accidentelle aux pesticides : à propos d’un cas |
| P44 | Djamaa S. Qualitative screening analysis of urine samples by GC-MS method: application in forensic toxicology |
| P45 | Dopierala A. Fatal intoxication involving 2,5-dimethoxy-4-chloroamphetamine (DOC): a case report |
| P46 | Dufayet L. Forensic pre-hospital deaths related to fentanyl and its analogues in the Paris area: data from the Île-de-France Toxic Death Surveillance System (DCTOX-IdF) |
| P47 | Eysseric H. Ethyl acetate from nail polish remover inhalation in a case of fatal voluntary intoxication |
| P48 | Fabris A. Development of a new green microextraction technique, Switchable Hydrophilicity Solvent-Based Homogenous Liquid–Liquid Microextraction, to analyze synthetic cannabinoids in plasma |
| P49 | Falck Jørgensen C. Quantification of endocannabinoids in human plasma |
| P50 | Fathy Ahmad W. Effects of tramadol abuse on plasma concentration of Leptin and Agouti Related Protein (AgRP) |
| P51 | Fearn D. First confirmation of synthetic cathinone N,N-dimethylpentylone in post-mortem sample in New Zealand using GC-MS/MS |
| P52 | Fogarty M. A novel approach to verifying and implementing a quantitative standard addition analysis of NPS drugs in forensic toxicology samples |
| P53 | Foray ME. Etude de l’interférence potentielle du cannabidiol (CBD) et de ses métabolites sur le dosage dans le plasma du delta-9-tétrahydrocannabinol (THC) et de ses métabolites par méthode LC-MS/MS |
| P54 | Franco Martins A. Quantitative evaluation of the composition of synthetic cannabinoid receptor agonists (SCRA) in infused papers and herbal materials seized in Brazilian prisons |
| P55 | Fung F. Reaching new sensitivity levels for the detection of fentanyl analogs and highly potent novel synthetic opioids in blood |
| P56 | Gao L. Drugs of abuse in meconium: analytical strategy and results |
| P57 | Gaugler S. High resolution, high accuracy non-targeted LC-HR-MS/MS Dried Urine Spot screening for drug of abuse testing |
| P58 | Gaulier JM. Evaluation of analytical performances of a serum acetaminophen assay designed for round-the-clock use |
| P59 | Goh EML. In vitro approaches for the identification and characterization of urinary metabolite biomarkers of synthetic cannabinoid ADB-BUTINACA |
| P60 | Goyal K. Financial heist from counterfeit drug: a case Study from Delhi, India |
| P61 | Gunja N. Food-borne methemoglobinemia in children |
| P62 | Gys C. Development, validation and application of a GC-MS method for quantification of glucose and lactate in vitreous humor |
| P63 | Hansen SL. Postmortem investigation of more than 100 consecutive autopsy cases in femoral blood, cardiac blood, brain tissue and muscle tissue |
| P64 | Harper CE. Drugged driving investigation workflow and oral fluid testing used around the world: survey results of SOFT/AAFS drugs and driving and oral fluid committees |
| P65 | Hemmer S. Emergency toxicology analysis – Method development for the straightforward determination of total 70 drugs and metabolites in human blood plasma by LC-MSn |
| P66 | Hermetet C. 2,4-dinitrophenol (2,4-DNP) poisoning in young athletes: clinical description of chronic exposure and public health perspectives – Around a case report |
| P67 | Høiseth G. Nystagmus among amphetamine-impaired drivers |
| P68 | Huertas T. Cannabis recent use in sudden unexpected deaths |
| P69 | Humbert L. Dosage de gamma-hydroxy butyrate sur Dried Blood Spot (DBS) par chromatographie en phase supercritique |
| P70 | Imran M. Quantitative analysis of phosphine in variety of biological samples from two cases of fatal poisoning |
| P71 | Isenschmid D. Detected drugs in homicides: A tale of two cities – Chicago and Detroit |
| P72 | Janeckova L. Counterfeits of Xanax – combination of designer benzodiazepines clonazepam and flualprazolam |
| P73 | Jannetto PJ. Fluoride toxicity: a tale of two sources |
| P74 | Janssens LK. Towards better understanding SCRAs and metabolites in recreational drug intoxications associated with 5F-MDMB-PICA use |
| P75 | Johansen JE. A review of nine years of NPS synthesis research projects supported by EUROSTARS |
| P76 | Jung Y. Contents of cannabinoids in commercial hemp seed oil capsules in Korea |
| P77 | Kang M. Nicotine poisoning-related deaths in Seoul Capital Area, Korea, 2014-2021 |
| P78 | Kankaanpää A. Regional changes in stimulant drug use during COVID-19 pandemic in Finland: a wastewater study |
| P79 | Kappatos D. Development and application of a real-time integrated Drugs Surveillance System (iDSS) for NPS in New Zealand |
| P80 | Kaudewitz J. Accumulation of amphetamine in hair after contact with street amphetamine |
| P81 | Kaudewitz J. Detection of drugs and metabolites in hair before and after treatment with freely available agents chosen to effectively remove drugs from the hair matrix – a case study |
| P82 | Kernalléguen A. Identification and quantitation of kratom in the hair of a regular user of substances purchased on the darkweb |
| P83 | Kiat W. Chronic methanol toxicity through topical and inhalational routes presenting as vision loss: case report |
| P84 | Kikura-Hanajiri R. The differentiation of LSD and its 17 related compounds by GC-EI-MS and GC-CI-QTOF-MS |
| P85 | Kim E. Current status of hair analysis on narcotics in Korea |
| P86 | Kim JY. Simultaneous determination of cocaine, cocaethylene, benzoylecgonine and ethyl glucuronide in hair from the cocaine and alcohol abusers by LC-MS/MS |
| P87 | Kim M. Determination of cannabinoids in illegal e-cigarette fluids in Korea by LC-MS/MS |
| P88 | Kinani A. High throughput online solid-phase extraction tandem mass spectrometry for immunosuppressive drugs determination in whole blood |
| P89 | Kolderová N. Chiral separation and characterization of methoxphenidine – A popular street drug |
| P90 | Kronstrand R. Quantification of THC, metabolites, and related compounds in whole blood using LC-MS/MS |
| P91 | Lacoursière J. SAMHSA drug panel screening in oral fluid: development of screening method at 8 seconds per sample using LDTD-MS/MS |
| P92 | Lapo S. THC and THC-COOH hair concentrations: influence of age, gender, consumption habits, hair morphology and cosmetics treatment |
| P93 | Lendoiro E. Usefulness of toxicology screening by High Resolution Mass Spectrometry in methamphetamine and amphetamine users attended in Emergency Departments |
| P94 | Lierheimer S. Comparison of electrospray and UniSpray™ ion sources with post-column hydrochloric acid infusion for 119 abuse relevant substances |
| P95 | Lindsay C. Form and content of Jamaican cannabis edibles |
| P96 | Liu H. New phosphatidylethanol (PEth) reference materials by chemical synthetic pathway |
| P97 | Lupo S. A multi-class drug and metabolite screen of 231 analytes by LC-MS/MS |
| P98 | Makanye L. Interdisciplinary approach to determining the use of drugs of abuse in wastewater using a survey and Gas Chromatography-Mass Spectrometry |
| P99 | Malaca S. In silico prediction, human hepatocyte metabolism, LC-HRMS/MS analysis, and targeted/nontargeted data-mining to characterize 4-acetoxy-N,N-diisopropyl-tryptamine metabolism |
| P100 | Malinescu B. Lethal intoxications of medical staff with substances used in the profession – presentation of a group of cases |
| P101 | Malokhat N. Development of methods of determination of biological liquids by high-performance liquid chromatography of acetamiprid pesticide |
| P102 | Mandour R. Domestic water and accumulating mercury toxicity in the kidney |
| P103 | Marikova T. Photocatalytic degradation of antibiotics under various conditions |
| P104 | Martin P. Synthesis of benzo-condensed cyclic cathinone derivatives |
| P105 | Mastrogianni O. Development and validation of a LC-MS/MS method for the determination of 25 drugs in cerumen and its application to real postmortem samples |
| P106 | Matheux A. Suicide of a young woman using a kit containing sodium nitrite ordered on the internet |
| P107 | Mathon C. Occurrence of GHB in blood and urine specimens from victims of alleged sexual assault or blackout in Western Switzerland |
| P108 | McCulloch M. The impact of imidacloprid and its metabolites on long–term neurodevelopmental and neurodegenerative disorders in a Zebrafish model |
| P109 | McMillan A. Automating DUID methods using robotics for rapid High Throughput Sample Preparation – Section 4 and Section 5A UK Road Traffic Act compounds in whole blood |
| P110 | Mcmillan D. Multi-panel detection of drugs and drug metabolites in hair samples using a comprehensive extraction method |
| P111 | Meda SD. Investigations toxicologiques dans un cas d’intoxication alimentaire collective d’une famille au Burkina Faso |
| P112 | Menendez MJ. Drug delivery homicide: a challenge for testimony from toxicologists |
| P113 | Minji K. Determination of flupyradifurone and its metabolite in postmortem blood by liquid chromatography-tandem mass spectrometry |
| P114 | Mishra A. Development of new spot test for the identification of ketamine and its application for forensic samples – Blood, injection, and viscera |
| P115 | Mishra A. Qualitative and quantitative evaluation of the physiologically active substances in commercially available Withania Somnifera supplements |
| P116 | Mistry N. An alternative workflow for drug analysis |
| P117 | Monteiro C. Ethanol and putrefaction: medicolegal relevance of the study of different biological samples |
| P118 | Monti M. Chemical differentiation of cannabis varieties applying targeted and untargeted analysis |
| P119 | Morla A. Highly sensitive MS/MS detection for confident identification of potent novel synthetic opioids and their metabolites |
| P120 | Mubasher M. Exhumation unveiled honor killing of a woman in Pakistan |
| P121 | Mubasher M. Simultaneous quantitation of commonly encountered drugs (lidocaine, orphenadrine, chlorpheniramine and chloroquine) in biological specimens using modified QuEChERS technique |
| P122 | Musile G. Creatinine determination by origami paper-based device for identifying urine adulteration |
| P123 | Muzikova B. The optimalization of photocatalytic degradation of 4-tert-octylphenol |
| P124 | Najamuddin N. Detection of phosphine in abdominal cavity material of woman dead body and ingesta of cow using Gas Chromatography-Nitrogen Phosphorous Detector technique (GC-NPD) |
| P125 | Negri P. Enhancing high-resolution mass spectrometry performance for NPS analysis with improved sensitivity and characterization |
| P126 | Noritake K. Fatal intoxication with a mixture of para-methoxyamphetamine, N-ethylpentylone, and ketamine |
| P127 | Norman C. Newly emerging synthetic cannabinoids and novel modes of use of benzodiazepines in prisons: an update from the Scottish Prisons Non-Judicial Seizures Drug Monitoring Project |
| P128 | Oyono Y. Prevalence of alcohol among drivers, riders and pedestrians injured in road traffic crashes in Cameroon: a cross-sectional study |
| P129 | Papoutsis I. Study on the distribution of quetiapine and its metabolites in vitreous humor |
| P130 | Park Y. Drug Trend Report 2017-2021 in Korea |
| P131 | Pascali J. Detection of multiple prohibited ingredients in nutritional supplements in a case of doping |
| P132 | Pasin D. Identification of the novel synthetic cannabinoid-type new psychoactive substance, CH-PIACA, in seized material |
| P133 | Pelissier-Alicot AL. Deaths related to the combination of pregabalin and other drugs of abuse: about two cases |
| P134 | Peres M. Two deaths after ingestion of a falsified pumpkin seed oil |
| P135 | Perrais M. Measurement of trace elements concentrations in human adipose tissue and links with phenotypic characteristics |
| P136 | Pinar EO. Evaluation of homogeneity in cocaine-impregnated papers: a pilot study |
| P137 | Proença P. LC-MS/MS-MS3 for determination and quantification of ∆9-tetrahydrocannabinol and metabolites in blood samples |
| P138 | Pulver B. Synthetic cannabinoids and their semi-systematic naming developed in Europe – Overview of the chemical diversity and practical guidelines |
| P139 | Pulver B. Synthetic cannabimimetics with cyclobutyl methyl and norbornyl methyl side chains – Pharmacological data and legislative implications |
| P140 | Rab E. Benefits of simultaneous screening and quantitation of drugs and their metabolites in post-mortem samples by liquid chromatography-high resolution mass spectrometry |
| P141 | Rachedi IR. A case report: fatal intoxication by simultaneous abuse of cocaine and ethyl alcohol |
| P142 | Rachedi IR. Acute toxicity due to delayed elimination of methotrexate in cancer therapy: a case report |
| P143 | Rana S. Cocaethylene presence in oral fluids from cocaine users |
| P144 | Resnik K. In vitro metabolic profile of the New Synthetic Opioid Bucinnazine by liquid chromatography tandem mass spectrometry (LC-MS/MS) |
| P145 | Reveil L. A determination of the aerosolization efficiency of drugs of abuse in a eutectic mixture with nicotine in electronic cigarettes |
| P146 | Riasat M. Sevoflurane analysis in forensic cases using Headspace-Gas Chromatography-Mass Spectrometry: a case study |
| P147 | Rodrigues LC. Use of solid phase microextraction in tips (SPME-Tips) for analysis of cocaine and biotransformation products in oral fluid by liquid chromatography tandem mass spectrometry (LC-MS/MS) |
| P148 | Rodrigues T. Prevalence of volatile organic compounds in forensic toxicology reports of São Paulo State |
| P149 | Romolo FS. On-site GC-QEPAS analysis on the scene of crime: the RISEN project |
| P150 | Roussel O. Gliclazide poisoning: when hair analysis supports a dispensing error! |
| P151 | Rubbens J. Sample preparation and quantitative UHPLC-MS/MS analysis in an accredited high-throughput environment: tips and tricks to improve your success ratio |
| P152 | Russell S. A survey of eutylone prevalence in New Zealand during 2020 and 2021 |
| P153 | Saka K. Simple and simultaneous quantification of cyanide, ethanol, and 1-propanol in blood by headspace GC–MS/NPD with a Deans switch |
| P154 | Salomone A. Assessment of recombinant beta-Glucuronidase vs native beta-Glucuronidase and alkaline conditions for the hydrolysis of THC-glucuronide |
| P155 | Salvador A. Forensic profiling of methamphetamine concealed in chinese teabags seized from multiple drug operations in the Philippines: a case report |
| P156 | Sarkisian M. Identification criteria, in-house compound libraries and SWATH: a benchmark implementation of quadrupole time-of-flight mass spectrometry in routine toxicological casework |
| P157 | Saskoy L. Back to the future: retrograde alcohol calculations an uncertain science |
| P158 | Saxena D. Partial hanging with multiple pesticide poisoning: a case report of a complex suicide |
| P159 | Sayaka N. An autopsy case of fatal insulin preparation overdose |
| P160 | Sekula K. Differentiation of cannabis types based on cannabinoid content |
| P161 | Shoff E. What once was old is new again: the emergence of traditional stimulants and hallucinogens in Miami-Dade County postmortem casework |
| P162 | Sim J. A lethal case of 4F-MDMB-BINACA poisoning |
| P163 | Sinha S. Spontaneous Explosion due to Volatile Inflammable Chemicals – Invisible explosives |
| P164 | Skov K. Improving analysis of urine samples from drug-facilitated sexual assault cases |
| P165 | Stockham P. Characteristics of patients positive for methamphetamine in the emergency department, and the influence of the co-administration of GHB |
| P166 | Stopnitskiy A. Effects of modern hepatoprotector on condition of the liver indicators and central nervous systems of patients with alcoholic toxic hepatitis |
| P167 | Sundermann TR. Cocaine derivatives – synthesis, analytical characterization and evaluation of their cross reactivity in immunochemical assays |
| P168 | Surenjav U. Prevalence of thyrotoxicosis in mongolia |
| P169 | Tanaka R. Analyses of LSD analogs in illegal products: the identification of 1cP-AL-LAD, 1cP-MIPLA and 1V-LSD |
| P170 | Taylor K. Review of findings in a case series of NPS benzodiazepines in UK deaths |
| P171 | Tini A. Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling (VAMS) and LC-MS/MS |
| P172 | Tonooka-Kubota K. Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of seventeen beta blockers |
| P173 | Toure A. Intoxications aux pesticides au Sénégal : données du centre Antipoison de 2009 à 2020 |
| P174 | Tytgat J. Delta-8-Tetrahydrocannabinol, an emerging NPS and other structurally related cannabinoids |
| P175 | Usman HF. A fatal case of carbofuran and para-phenylenediamine poisoning: a death mystery resolved |
| P176 | Vagnerova M. Novel method for determination of methoxphenidine and its main metabolite in biological samples |
| P177 | Vaiano F. Intoxication by drugs of abuse in paediatric age in Florence: a 5-years study |
| P178 | Van Wichelen N. Refining wastewater-based epidemiology for cannabis consumption monitoring: relevance of analysing both the aqueous phase and suspended solids of influent wastewater |
| P179 | Vancea S. 3,5-Dimethoxyphenol identification from urine by GC-MS after a lethal intoxication with Taxus baccata: a case report |
| P180 | Verma Y. Toxicity risk assessment in tobacco chewers, cigarette smokers and alcohol consumers using urinary DNA adduct and exfoliated buccal cells micronuclei as non invasive biomarkers |
| P181 | Verougstraete N. First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne): a recent addition to the nitazene opioid subclass |
| P182 | Vikingsson S. Relative hydroxy-cocaine concentrations a possible marker for cocaine use? |
| P183 | Walle N. Can postmortem toxicological findings be influenced by a further release of fentanyl from transdermal patches? – A pilot study using the pig model |
| P184 | Webling K. Characterization of metabolites from 4CN-MDMB-BUTINACA and Benzyl-4CN-BUTINACA using human hepatocytes followed by LC-QTOF-MS analysis |
| P185 | Weinmann W. Dried blood spot (DBS) for ethyl glucuronide (EtG) and ethyl sulfate (EtS) determination in blood with a new design of “volumetric” DBS filter paper card |
| P186 | Yang CH. Designer benzodiazepines and their metabolites in post- and antemortem specimens: quantitation by UHPLC-MS/MS and findings in Taiwan |
| P187 | Yao YJ. Suicide by sodium nitrite – an emerging trend |
| P188 | Zakirdjan Y. Development of methods for separation of imidacloprid and acetamiprid from biological liquids |
| P189 | Zebbiche Y. Biomonitoring of exposure of algerian population to lead |
| P190 | Matey JM. What do we know about the positional isomers of 2C-B? Study through real hair cases: the role of high-resolution mass spectrometry (HRMS) |